These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33529569)

  • 1. SARS-CoV-2 Seropositivity among US Marine Recruits Attending Basic Training, United States, Spring-Fall 2020.
    Letizia AG; Ge Y; Goforth CW; Weir DL; Lizewski R; Lizewski S; Soares-Schanoski A; Vangeti S; Marjanovic N; Sealfon SC; Ramos I
    Emerg Infect Dis; 2021 Apr; 27(4):1188-1192. PubMed ID: 33529569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020.
    Shakiba M; Nazemipour M; Salari A; Mehrabian F; Nazari SSH; Rezvani SM; Ghasempour Z; Heidarzadeh A; Mansournia MA
    Emerg Infect Dis; 2021 Feb; 27(2):636-638. PubMed ID: 33349310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.
    Weis S; Scherag A; Baier M; Kiehntopf M; Kamradt T; Kolanos S; Ankert J; Glöckner S; Makarewicz O; Hagel S; Bahrs C; Kimmig A; Proquitté H; Guerra J; Rimek D; Löffler B; Pletz MW;
    Clin Microbiol Infect; 2021 Mar; 27(3):470.e1-470.e9. PubMed ID: 33221432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Transmission among Marine Recruits during Quarantine.
    Letizia AG; Ramos I; Obla A; Goforth C; Weir DL; Ge Y; Bamman MM; Dutta J; Ellis E; Estrella L; George MC; Gonzalez-Reiche AS; Graham WD; van de Guchte A; Gutierrez R; Jones F; Kalomoiri A; Lizewski R; Lizewski S; Marayag J; Marjanovic N; Millar EV; Nair VD; Nudelman G; Nunez E; Pike BL; Porter C; Regeimbal J; Rirak S; Santa Ana E; Sealfon RSG; Sebra R; Simons MP; Soares-Schanoski A; Sugiharto V; Termini M; Vangeti S; Williams C; Troyanskaya OG; van Bakel H; Sealfon SC
    N Engl J Med; 2020 Dec; 383(25):2407-2416. PubMed ID: 33176093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of SARS-CoV-2-Specific Antibodies, Japan, June 2020.
    Yoshiyama T; Saito Y; Masuda K; Nakanishi Y; Kido Y; Uchimura K; Mitarai S; Suzuki T; Nakagama Y; Kubota H; Satomi M; Uchikoba S; Ohnishi M; Wakita T; Kato S; Kato K
    Emerg Infect Dis; 2021 Feb; 27(2):628-631. PubMed ID: 33496235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of SARS-CoV-2 N-Antibody Response in Healthcare Workers, London, UK.
    Shrotri M; Harris RJ; Rodger A; Planche T; Sanderson F; Mahungu T; McGregor A; Heath PT; ; Brown CS; Dunning J; Hopkins S; Ladhani S; Chand M
    Emerg Infect Dis; 2021 Apr; 27(4):1155-1158. PubMed ID: 33734962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure.
    Hunter BR; Dbeibo L; Weaver CS; Beeler C; Saysana M; Zimmerman MK; Weaver L
    Infect Control Hosp Epidemiol; 2020 Dec; 41(12):1441-1442. PubMed ID: 32741406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020.
    Kar SS; Sarkar S; Murali S; Dhodapkar R; Joseph NM; Aggarwal R
    Emerg Infect Dis; 2021 Feb; 27(2):666-669. PubMed ID: 33496645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remote Fingerstick Blood Collection for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Testing.
    Garcia-Beltran WF; Miller TE; Kirkpatrick G; Nixon A; Astudillo MG; Yang D; Mahanta LM; Murali M; Dighe AS; Lennerz J; Thierauf J; Naranbhai V; Iafrate AJ
    Arch Pathol Lab Med; 2021 Apr; 145(4):415-418. PubMed ID: 33264390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.
    Saeed S; Drews SJ; Pambrun C; Yi QL; Osmond L; O'Brien SF
    Transfusion; 2021 Mar; 61(3):862-872. PubMed ID: 33527398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Infection and Mitigation Efforts among Office Workers, Washington, DC, USA.
    Sami S; Vuong N; Miller H; Priestley R; Payne M; Licata-Portentoso G; Drobeniuc J; Petersen LR
    Emerg Infect Dis; 2021 Feb; 27(2):669-672. PubMed ID: 33496649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming spectrum bias for accurate SARS-CoV-2 seroprevalence estimates.
    Puhan MA; Chiolero A; Fehr J; Cullati S;
    BMJ; 2021 Apr; 373():n917. PubMed ID: 33846210
    [No Abstract]   [Full Text] [Related]  

  • 13. Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Inflammatory Bowel Disease Under Biologic Treatment.
    Norsa L; Cosimo P; Indriolo A; Sansotta N; D'Antiga L; Callegaro A
    Gastroenterology; 2020 Dec; 159(6):2229-2231.e2. PubMed ID: 32860790
    [No Abstract]   [Full Text] [Related]  

  • 14. The seroprevalence of SARS-CoV-2 in a rural southwest community.
    Santarelli A; Lalitsasivimol D; Bartholomew N; Reid S; Reid J; Lyon C; Wells J; Ashurst J
    J Osteopath Med; 2021 Feb; 121(2):199-210. PubMed ID: 33567087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States.
    Bailey LC; Razzaghi H; Burrows EK; Bunnell HT; Camacho PEF; Christakis DA; Eckrich D; Kitzmiller M; Lin SM; Magnusen BC; Newland J; Pajor NM; Ranade D; Rao S; Sofela O; Zahner J; Bruno C; Forrest CB
    JAMA Pediatr; 2021 Feb; 175(2):176-184. PubMed ID: 33226415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-Based Serosurvey for Severe Acute Respiratory Syndrome Coronavirus 2 Transmission, Chennai, India.
    Selvaraju S; Kumar MS; Thangaraj JWV; Bhatnagar T; Saravanakumar V; Kumar CPG; Sekar K; Ilayaperumal E; Sabarinathan R; Jagadeesan M; Hemalatha MS; Murhekar MV;
    Emerg Infect Dis; 2021 Feb; 27(2):586-589. PubMed ID: 33496222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients.
    Del Zompo F; De Maio F; Santopaolo F; Ricci R; Gasbarrini A; Pompili M; Ponziani FR
    Dig Liver Dis; 2021 May; 53(5):541-544. PubMed ID: 33707148
    [No Abstract]   [Full Text] [Related]  

  • 18. SARS-CoV-2 Outbreak Dynamics in an Isolated US Military Recruit Training Center With Rigorous Prevention Measures.
    Lizewski RA; Sealfon RSG; Park SW; Smith GR; Porter CK; Gonzalez-Reiche AS; Ge Y; Miller CM; Goforth CW; Pincas H; Termini MS; Ramos I; Nair VD; Lizewski SE; Alshammary H; Cer RZ; Chen HW; George MC; Arnold CE; Glang LA; Long KA; Malagon F; Marayag JJ; Nunez E; Rice GK; Santa Ana E; Schilling MA; Smith DR; Sugiharto VA; Sun P; van de Guchte A; Khan Z; Dutta J; Vangeti S; Voegtly LJ; Weir DL; Metcalf CJE; Troyanskaya OG; Bishop-Lilly KA; Grenfell BT; van Bakel H; Letizia AG; Sealfon SC
    Epidemiology; 2022 Nov; 33(6):797-807. PubMed ID: 35944149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis.
    Berardis S; Verroken A; Vetillart A; Struyf C; Gilbert M; Gruson D; Gohy S
    J Cyst Fibros; 2020 Nov; 19(6):872-874. PubMed ID: 32828701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of SARS-CoV-2 Antibodies in First Responders and Public Safety Personnel, New York City, New York, USA, May-July 2020.
    Sami S; Akinbami LJ; Petersen LR; Crawley A; Lukacs SL; Weiss D; Henseler RA; Vuong N; Mackey L; Patel A; Grohskopf LA; Morgenthau BM; Daskalakis D; Pathela P
    Emerg Infect Dis; 2021 Mar; 27(3):796-804. PubMed ID: 33493106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.